Examining Cutaneous Disease Activity as an Outcome Measure for Clinical Trials in Dermatomyositis
April 2018
in “
Journal of Investigative Dermatology
”
Studysummary This study suggests that for dermatomyositis patients with minimal skin disease activity, further improvement in cutaneous symptoms may not translate into better quality of life, highlighting a need to revise trial endpoints.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jidonline.org →